Global Prescription Migraine Medicine Supply, Demand and Key Producers, 2023-2029

July 2024 | 97 pages | ID: G483105AD586EN
GlobalInfoResearch

Abstracts

The global Prescription Migraine Medicine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Headaches and migraines are common conditions affecting a significant portion of the population. The increasing prevalence of these conditions drives the demand for prescription headache medicines as individuals seek effective treatment options to manage their symptoms. While over-the-counter medications can provide relief for many individuals with mild headaches, there is a substantial population that experiences moderate to severe headaches or migraines that require stronger prescription medications. The unmet medical needs of this population drive the demand for prescription headache medicines.
Prescription migraine medicines are medications that require a doctor's prescription and are specifically designed to treat migraines. These medications are typically more potent and targeted in their approach to managing migraine symptoms.
This report studies the global Prescription Migraine Medicine demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Prescription Migraine Medicine, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Prescription Migraine Medicine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Prescription Migraine Medicine total market, 2018-2029, (USD Million)
Global Prescription Migraine Medicine total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Prescription Migraine Medicine total market, key domestic companies and share, (USD Million)
Global Prescription Migraine Medicine revenue by player and market share 2018-2023, (USD Million)
Global Prescription Migraine Medicine total market by Type, CAGR, 2018-2029, (USD Million)
Global Prescription Migraine Medicine total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Prescription Migraine Medicine market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, Teva, Pfizer, Amgen, Viatris, Allergan, Grunenthal and Eli Lilly, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Prescription Migraine Medicine market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Prescription Migraine Medicine Market, By Region:

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India
• Rest of World

Global Prescription Migraine Medicine Market, Segmentation by Type

• Sumatriptan
• Rizatriptan
• Others

Global Prescription Migraine Medicine Market, Segmentation by Application

• Hospital
• Clinic
• Drug Store

Companies Profiled:

• GSK
• Teva
• Pfizer
• Amgen
• Viatris
• Allergan
• Grunenthal
• Eli Lilly

Key Questions Answered
1. How big is the global Prescription Migraine Medicine market?
2. What is the demand of the global Prescription Migraine Medicine market?
3. What is the year over year growth of the global Prescription Migraine Medicine market?
4. What is the total value of the global Prescription Migraine Medicine market?
5. Who are the major players in the global Prescription Migraine Medicine market?
6. What are the growth factors driving the market demand?

Contents

1 SUPPLY SUMMARY

1.1 Prescription Migraine Medicine Introduction
1.2 World Prescription Migraine Medicine Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Prescription Migraine Medicine Total Market by Region (by Headquarter Location)
  1.3.1 World Prescription Migraine Medicine Market Size by Region (2018-2029), (by Headquarter Location)
  1.3.2 United States Prescription Migraine Medicine Market Size (2018-2029)
  1.3.3 China Prescription Migraine Medicine Market Size (2018-2029)
  1.3.4 Europe Prescription Migraine Medicine Market Size (2018-2029)
  1.3.5 Japan Prescription Migraine Medicine Market Size (2018-2029)
  1.3.6 South Korea Prescription Migraine Medicine Market Size (2018-2029)
  1.3.7 ASEAN Prescription Migraine Medicine Market Size (2018-2029)
  1.3.8 India Prescription Migraine Medicine Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Prescription Migraine Medicine Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Prescription Migraine Medicine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World Prescription Migraine Medicine Consumption Value (2018-2029)
2.2 World Prescription Migraine Medicine Consumption Value by Region
  2.2.1 World Prescription Migraine Medicine Consumption Value by Region (2018-2023)
  2.2.2 World Prescription Migraine Medicine Consumption Value Forecast by Region (2024-2029)
2.3 United States Prescription Migraine Medicine Consumption Value (2018-2029)
2.4 China Prescription Migraine Medicine Consumption Value (2018-2029)
2.5 Europe Prescription Migraine Medicine Consumption Value (2018-2029)
2.6 Japan Prescription Migraine Medicine Consumption Value (2018-2029)
2.7 South Korea Prescription Migraine Medicine Consumption Value (2018-2029)
2.8 ASEAN Prescription Migraine Medicine Consumption Value (2018-2029)
2.9 India Prescription Migraine Medicine Consumption Value (2018-2029)

3 WORLD PRESCRIPTION MIGRAINE MEDICINE COMPANIES COMPETITIVE ANALYSIS

3.1 World Prescription Migraine Medicine Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global Prescription Migraine Medicine Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for Prescription Migraine Medicine in 2022
  3.2.3 Global Concentration Ratios (CR8) for Prescription Migraine Medicine in 2022
3.3 Prescription Migraine Medicine Company Evaluation Quadrant
3.4 Prescription Migraine Medicine Market: Overall Company Footprint Analysis
  3.4.1 Prescription Migraine Medicine Market: Region Footprint
  3.4.2 Prescription Migraine Medicine Market: Company Product Type Footprint
  3.4.3 Prescription Migraine Medicine Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: Prescription Migraine Medicine Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: Prescription Migraine Medicine Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
  4.1.2 United States VS China: Prescription Migraine Medicine Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Prescription Migraine Medicine Consumption Value Comparison
  4.2.1 United States VS China: Prescription Migraine Medicine Consumption Value Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: Prescription Migraine Medicine Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Prescription Migraine Medicine Companies and Market Share, 2018-2023
  4.3.1 United States Based Prescription Migraine Medicine Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies Prescription Migraine Medicine Revenue, (2018-2023)
4.4 China Based Companies Prescription Migraine Medicine Revenue and Market Share, 2018-2023
  4.4.1 China Based Prescription Migraine Medicine Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies Prescription Migraine Medicine Revenue, (2018-2023)
4.5 Rest of World Based Prescription Migraine Medicine Companies and Market Share, 2018-2023
  4.5.1 Rest of World Based Prescription Migraine Medicine Companies, Headquarters (States, Country)
  4.5.2 Rest of World Based Companies Prescription Migraine Medicine Revenue, (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World Prescription Migraine Medicine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 Sumatriptan
  5.2.2 Rizatriptan
  5.2.3 Others
5.3 Market Segment by Type
  5.3.1 World Prescription Migraine Medicine Market Size by Type (2018-2023)
  5.3.2 World Prescription Migraine Medicine Market Size by Type (2024-2029)
  5.3.3 World Prescription Migraine Medicine Market Size Market Share by Type (2018-2029)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Prescription Migraine Medicine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
  6.2.1 Hospital
  6.2.2 Clinic
  6.2.3 Drug Store
6.3 Market Segment by Application
  6.3.1 World Prescription Migraine Medicine Market Size by Application (2018-2023)
  6.3.2 World Prescription Migraine Medicine Market Size by Application (2024-2029)
  6.3.3 World Prescription Migraine Medicine Market Size by Application (2018-2029)

7 COMPANY PROFILES

7.1 GSK
  7.1.1 GSK Details
  7.1.2 GSK Major Business
  7.1.3 GSK Prescription Migraine Medicine Product and Services
  7.1.4 GSK Prescription Migraine Medicine Revenue, Gross Margin and Market Share (2018-2023)
  7.1.5 GSK Recent Developments/Updates
  7.1.6 GSK Competitive Strengths & Weaknesses
7.2 Teva
  7.2.1 Teva Details
  7.2.2 Teva Major Business
  7.2.3 Teva Prescription Migraine Medicine Product and Services
  7.2.4 Teva Prescription Migraine Medicine Revenue, Gross Margin and Market Share (2018-2023)
  7.2.5 Teva Recent Developments/Updates
  7.2.6 Teva Competitive Strengths & Weaknesses
7.3 Pfizer
  7.3.1 Pfizer Details
  7.3.2 Pfizer Major Business
  7.3.3 Pfizer Prescription Migraine Medicine Product and Services
  7.3.4 Pfizer Prescription Migraine Medicine Revenue, Gross Margin and Market Share (2018-2023)
  7.3.5 Pfizer Recent Developments/Updates
  7.3.6 Pfizer Competitive Strengths & Weaknesses
7.4 Amgen
  7.4.1 Amgen Details
  7.4.2 Amgen Major Business
  7.4.3 Amgen Prescription Migraine Medicine Product and Services
  7.4.4 Amgen Prescription Migraine Medicine Revenue, Gross Margin and Market Share (2018-2023)
  7.4.5 Amgen Recent Developments/Updates
  7.4.6 Amgen Competitive Strengths & Weaknesses
7.5 Viatris
  7.5.1 Viatris Details
  7.5.2 Viatris Major Business
  7.5.3 Viatris Prescription Migraine Medicine Product and Services
  7.5.4 Viatris Prescription Migraine Medicine Revenue, Gross Margin and Market Share (2018-2023)
  7.5.5 Viatris Recent Developments/Updates
  7.5.6 Viatris Competitive Strengths & Weaknesses
7.6 Allergan
  7.6.1 Allergan Details
  7.6.2 Allergan Major Business
  7.6.3 Allergan Prescription Migraine Medicine Product and Services
  7.6.4 Allergan Prescription Migraine Medicine Revenue, Gross Margin and Market Share (2018-2023)
  7.6.5 Allergan Recent Developments/Updates
  7.6.6 Allergan Competitive Strengths & Weaknesses
7.7 Grunenthal
  7.7.1 Grunenthal Details
  7.7.2 Grunenthal Major Business
  7.7.3 Grunenthal Prescription Migraine Medicine Product and Services
  7.7.4 Grunenthal Prescription Migraine Medicine Revenue, Gross Margin and Market Share (2018-2023)
  7.7.5 Grunenthal Recent Developments/Updates
  7.7.6 Grunenthal Competitive Strengths & Weaknesses
7.8 Eli Lilly
  7.8.1 Eli Lilly Details
  7.8.2 Eli Lilly Major Business
  7.8.3 Eli Lilly Prescription Migraine Medicine Product and Services
  7.8.4 Eli Lilly Prescription Migraine Medicine Revenue, Gross Margin and Market Share (2018-2023)
  7.8.5 Eli Lilly Recent Developments/Updates
  7.8.6 Eli Lilly Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Prescription Migraine Medicine Industry Chain
8.2 Prescription Migraine Medicine Upstream Analysis
8.3 Prescription Migraine Medicine Midstream Analysis
8.4 Prescription Migraine Medicine Downstream Analysis

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. World Prescription Migraine Medicine Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Prescription Migraine Medicine Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Prescription Migraine Medicine Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Prescription Migraine Medicine Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Prescription Migraine Medicine Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Prescription Migraine Medicine Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Prescription Migraine Medicine Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Prescription Migraine Medicine Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Prescription Migraine Medicine Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Prescription Migraine Medicine Players in 2022
Table 12. World Prescription Migraine Medicine Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Prescription Migraine Medicine Company Evaluation Quadrant
Table 14. Head Office of Key Prescription Migraine Medicine Player
Table 15. Prescription Migraine Medicine Market: Company Product Type Footprint
Table 16. Prescription Migraine Medicine Market: Company Product Application Footprint
Table 17. Prescription Migraine Medicine Mergers & Acquisitions Activity
Table 18. United States VS China Prescription Migraine Medicine Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Prescription Migraine Medicine Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Prescription Migraine Medicine Companies, Headquarters (States, Country)
Table 21. United States Based Companies Prescription Migraine Medicine Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Prescription Migraine Medicine Revenue Market Share (2018-2023)
Table 23. China Based Prescription Migraine Medicine Companies, Headquarters (Province, Country)
Table 24. China Based Companies Prescription Migraine Medicine Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Prescription Migraine Medicine Revenue Market Share (2018-2023)
Table 26. Rest of World Based Prescription Migraine Medicine Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Prescription Migraine Medicine Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Prescription Migraine Medicine Revenue Market Share (2018-2023)
Table 29. World Prescription Migraine Medicine Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Prescription Migraine Medicine Market Size by Type (2018-2023) & (USD Million)
Table 31. World Prescription Migraine Medicine Market Size by Type (2024-2029) & (USD Million)
Table 32. World Prescription Migraine Medicine Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Prescription Migraine Medicine Market Size by Application (2018-2023) & (USD Million)
Table 34. World Prescription Migraine Medicine Market Size by Application (2024-2029) & (USD Million)
Table 35. GSK Basic Information, Area Served and Competitors
Table 36. GSK Major Business
Table 37. GSK Prescription Migraine Medicine Product and Services
Table 38. GSK Prescription Migraine Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. GSK Recent Developments/Updates
Table 40. GSK Competitive Strengths & Weaknesses
Table 41. Teva Basic Information, Area Served and Competitors
Table 42. Teva Major Business
Table 43. Teva Prescription Migraine Medicine Product and Services
Table 44. Teva Prescription Migraine Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Teva Recent Developments/Updates
Table 46. Teva Competitive Strengths & Weaknesses
Table 47. Pfizer Basic Information, Area Served and Competitors
Table 48. Pfizer Major Business
Table 49. Pfizer Prescription Migraine Medicine Product and Services
Table 50. Pfizer Prescription Migraine Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Pfizer Recent Developments/Updates
Table 52. Pfizer Competitive Strengths & Weaknesses
Table 53. Amgen Basic Information, Area Served and Competitors
Table 54. Amgen Major Business
Table 55. Amgen Prescription Migraine Medicine Product and Services
Table 56. Amgen Prescription Migraine Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Amgen Recent Developments/Updates
Table 58. Amgen Competitive Strengths & Weaknesses
Table 59. Viatris Basic Information, Area Served and Competitors
Table 60. Viatris Major Business
Table 61. Viatris Prescription Migraine Medicine Product and Services
Table 62. Viatris Prescription Migraine Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Viatris Recent Developments/Updates
Table 64. Viatris Competitive Strengths & Weaknesses
Table 65. Allergan Basic Information, Area Served and Competitors
Table 66. Allergan Major Business
Table 67. Allergan Prescription Migraine Medicine Product and Services
Table 68. Allergan Prescription Migraine Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Allergan Recent Developments/Updates
Table 70. Allergan Competitive Strengths & Weaknesses
Table 71. Grunenthal Basic Information, Area Served and Competitors
Table 72. Grunenthal Major Business
Table 73. Grunenthal Prescription Migraine Medicine Product and Services
Table 74. Grunenthal Prescription Migraine Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Grunenthal Recent Developments/Updates
Table 76. Eli Lilly Basic Information, Area Served and Competitors
Table 77. Eli Lilly Major Business
Table 78. Eli Lilly Prescription Migraine Medicine Product and Services
Table 79. Eli Lilly Prescription Migraine Medicine Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 80. Global Key Players of Prescription Migraine Medicine Upstream (Raw Materials)
Table 81. Prescription Migraine Medicine Typical Customers
List of Figure
Figure 1. Prescription Migraine Medicine Picture
Figure 2. World Prescription Migraine Medicine Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Prescription Migraine Medicine Total Market Size (2018-2029) & (USD Million)
Figure 4. World Prescription Migraine Medicine Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Prescription Migraine Medicine Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Prescription Migraine Medicine Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Prescription Migraine Medicine Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Prescription Migraine Medicine Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Prescription Migraine Medicine Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Prescription Migraine Medicine Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Prescription Migraine Medicine Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Prescription Migraine Medicine Revenue (2018-2029) & (USD Million)
Figure 13. Prescription Migraine Medicine Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Prescription Migraine Medicine Consumption Value (2018-2029) & (USD Million)
Figure 16. World Prescription Migraine Medicine Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Prescription Migraine Medicine Consumption Value (2018-2029) & (USD Million)
Figure 18. China Prescription Migraine Medicine Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Prescription Migraine Medicine Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Prescription Migraine Medicine Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Prescription Migraine Medicine Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Prescription Migraine Medicine Consumption Value (2018-2029) & (USD Million)
Figure 23. India Prescription Migraine Medicine Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Prescription Migraine Medicine by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Prescription Migraine Medicine Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Prescription Migraine Medicine Markets in 2022
Figure 27. United States VS China: Prescription Migraine Medicine Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Prescription Migraine Medicine Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Prescription Migraine Medicine Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Prescription Migraine Medicine Market Size Market Share by Type in 2022
Figure 31. Sumatriptan
Figure 32. Rizatriptan
Figure 33. Others
Figure 34. World Prescription Migraine Medicine Market Size Market Share by Type (2018-2029)
Figure 35. World Prescription Migraine Medicine Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Prescription Migraine Medicine Market Size Market Share by Application in 2022
Figure 37. Hospital
Figure 38. Clinic
Figure 39. Drug Store
Figure 40. Prescription Migraine Medicine Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source